Rapid Therapeutic Science Laboratories Inc logo

RTSL - Rapid Therapeutic Science Laboratories Inc Share Price

$0.87 0.0  0.0%

Last Trade - 23/10/20

Sector
Healthcare
Size
Small Cap
Market Cap £109.6m
Enterprise Value £110.4m
Revenue £106k
Position in Universe 4081st / 6447
Bullish
Bearish
Unlock RTSL Revenue
Momentum
Relative Strength (%)
1m +5.44%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -56.5%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.000 0.000 0.000 0.000 0.000 0.009
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the three months ended 30 June 2020, RapidTherapeutic Science Laborators Inc revenues increased from$0K to $129K. Net loss increased from $69K to $566K.Revenues reflect an increase in demand for the Company'sproducts and services due to favorable market conditions.Higher net loss reflects General and administrativeincrease from $23K to $630K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

RTSL Revenue Unlock RTSL Revenue

Net Income

RTSL Net Income Unlock RTSL Revenue

Normalised EPS

RTSL Normalised EPS Unlock RTSL Revenue

PE Ratio Range

RTSL PE Ratio Range Unlock RTSL Revenue

Dividend Yield Range

RTSL Dividend Yield Range Unlock RTSL Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
RTSL EPS Forecasts Unlock RTSL Revenue
Profile Summary

Rapid Therapeutic Science Laboratories Inc, formerly Holly Brothers Pictures, Inc., plans to re-build primarily electric or power wheelchairs in disrepair. The Company plans to market its services to repair and sell wheelchairs. Electric wheelchairs are for people who need support for their upper body and who are unable to move a manual chair with their arms and hands. The Company plans to market its services to doctors, therapists and home healthcare agencies in the Ohio, Eastern Indiana and Northern Kentucky areas. The wheelchairs can be customized for a user's needs, which may include the seat dimensions, height, seat angle (also called seat dump or squeeze), footrests, leg rests, front caster outriggers, adjustable backrests and controls. Additional customizations can include various optional accessories, such as anti-tip bars or wheels, adjustable backrests, tilt and recline features, extra support for limbs or neck, walkers or oxygen tanks, drink holders and clothing protectors.

Directors
Last Annual March 31st, 2020
Last Interim June 30th, 2020
Incorporated February 22, 2013
Public Since October 31, 2013
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index
Exchange Pink Sheets on Nasdaq
Shares in Issue 164,278,334
Free Float (0.0%)
Eligible for
ISAs
SIPPs
RTSL Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for RTSL
Upcoming Events for RTSL
Frequently Asked Questions for Rapid Therapeutic Science Laboratories Inc
What is the Rapid Therapeutic Science Laboratories Inc share price?

As of 23/10/20, shares in Rapid Therapeutic Science Laboratories Inc are trading at $0.87, giving the company a market capitalisation of £109.6m. This share price information is delayed by 15 minutes.

How has the Rapid Therapeutic Science Laboratories Inc share price performed this year?

Shares in Rapid Therapeutic Science Laboratories Inc are currently trading at $0.87 and the price has moved by 0.190k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Rapid Therapeutic Science Laboratories Inc price has moved by 0.167k% over the past year.

What are the analyst and broker recommendations for Rapid Therapeutic Science Laboratories Inc?

There are no analysts currently covering Rapid Therapeutic Science Laboratories Inc.

When will Rapid Therapeutic Science Laboratories Inc next release its financial results?

Rapid Therapeutic Science Laboratories Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the Rapid Therapeutic Science Laboratories Inc dividend yield?

Rapid Therapeutic Science Laboratories Inc does not currently pay a dividend.

Does Rapid Therapeutic Science Laboratories Inc pay a dividend?

Rapid Therapeutic Science Laboratories Inc does not currently pay a dividend.

When does Rapid Therapeutic Science Laboratories Inc next pay dividends?

Rapid Therapeutic Science Laboratories Inc does not currently pay a dividend.

How do I buy Rapid Therapeutic Science Laboratories Inc shares?

To buy shares in Rapid Therapeutic Science Laboratories Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Rapid Therapeutic Science Laboratories Inc?

Shares in Rapid Therapeutic Science Laboratories Inc are currently trading at $0.87, giving the company a market capitalisation of £109.6m.

Where are Rapid Therapeutic Science Laboratories Inc shares listed? Where are Rapid Therapeutic Science Laboratories Inc shares listed?

Here are the trading details for Rapid Therapeutic Science Laboratories Inc:

Country of listing: United States
Exchange: PNK
Ticker Symbol: RTSL
What kind of share is Rapid Therapeutic Science Laboratories Inc?

Based on an overall assessment of its quality, value and momentum, Rapid Therapeutic Science Laboratories Inc is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Rapid Therapeutic Science Laboratories Inc share price forecast 2020?

We were not able to load any forecast data for Rapid Therapeutic Science Laboratories Inc.

How can I tell whether the Rapid Therapeutic Science Laboratories Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Rapid Therapeutic Science Laboratories Inc. Over the past six months, the relative strength of its shares against the market has been 0.161k%. At the current price of $0.87, shares in Rapid Therapeutic Science Laboratories Inc are trading at -3.7% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Rapid Therapeutic Science Laboratories Inc PE Ratio?

We were not able to find PE ratio data for Rapid Therapeutic Science Laboratories Inc.

Who are the key directors of Rapid Therapeutic Science Laboratories Inc?

Rapid Therapeutic Science Laboratories Inc's management team is headed by:

Brent Willson - DRC
Steve Bond - DRC
Donal Schmidt - PRE
D. Hughes Watler - CFO
Who are the major shareholders of Rapid Therapeutic Science Laboratories Inc?

Here are the top five shareholders of Rapid Therapeutic Science Laboratories Inc based on the size of their shareholding:

Texas MDI Inc Corporation
Percentage owned: 85.22% (140.0m shares)
Willson (Brent) Individual Investor
Percentage owned: 0.46% (750k shares)
Bond (Steve) Individual Investor
Percentage owned: 0.15% (250k shares)
Similar to RTSL
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.